Caiming Xu

1.8k total citations
56 papers, 1.2k citations indexed

About

Caiming Xu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Caiming Xu has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Surgery and 14 papers in Oncology. Recurrent topics in Caiming Xu's work include Pancreatitis Pathology and Treatment (16 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Circular RNAs in diseases (5 papers). Caiming Xu is often cited by papers focused on Pancreatitis Pathology and Treatment (16 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Circular RNAs in diseases (5 papers). Caiming Xu collaborates with scholars based in China, United States and Japan. Caiming Xu's co-authors include Hailong Chen, Guixin Zhang, Yalan Luo, Peng Ge, Jiayue Liu, Ajay Goel, Haiyang Chen, Lei Li, Michael Ntim and Tikam Chand Dakal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cancer Research.

In The Last Decade

Caiming Xu

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caiming Xu China 21 456 340 269 241 237 56 1.2k
Jianyu Hao China 20 513 1.1× 444 1.3× 298 1.1× 177 0.7× 128 0.5× 64 1.5k
Xiaohua Wang China 23 580 1.3× 175 0.5× 309 1.1× 320 1.3× 231 1.0× 98 1.5k
Xi Yu China 23 547 1.2× 155 0.5× 265 1.0× 202 0.8× 137 0.6× 64 1.4k
Lei Gao China 21 647 1.4× 209 0.6× 176 0.7× 186 0.8× 180 0.8× 123 1.5k
Wenxian Guan China 18 443 1.0× 219 0.6× 207 0.8× 173 0.7× 430 1.8× 50 1.3k
Wenfu Tang China 20 570 1.3× 725 2.1× 304 1.1× 211 0.9× 231 1.0× 66 1.5k
Yingjie Li China 21 397 0.9× 202 0.6× 371 1.4× 120 0.5× 188 0.8× 84 1.1k
Hua Xiao China 22 508 1.1× 364 1.1× 356 1.3× 309 1.3× 119 0.5× 91 1.3k

Countries citing papers authored by Caiming Xu

Since Specialization
Citations

This map shows the geographic impact of Caiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caiming Xu more than expected).

Fields of papers citing papers by Caiming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caiming Xu. The network helps show where Caiming Xu may publish in the future.

Co-authorship network of co-authors of Caiming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Caiming Xu. A scholar is included among the top collaborators of Caiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caiming Xu. Caiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Peng, et al.. (2025). Costunolide: Targeting endothelial cell PANoptosis to mitigate lung injury in acute pancreatitis mice. Phytomedicine. 142. 156767–156767. 3 indexed citations
3.
Li, Yuan, et al.. (2024). Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. Pharmaceuticals. 17(7). 911–911. 6 indexed citations
4.
Dakal, Tikam Chand, Ravi Bhushan, Caiming Xu, et al.. (2024). Intricate relationship between cancer stemness, metastasis, and drug resistance. SHILAP Revista de lepidopterología. 5(10). e710–e710. 29 indexed citations
5.
Dakal, Tikam Chand, Nancy George, Caiming Xu, Prashanth Suravajhala, & Abhishek Kumar. (2024). Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types. Cancers. 16(9). 1626–1626. 12 indexed citations
6.
Ge, Peng, Yalan Luo, Jinquan Zhang, et al.. (2024). Mechanism Investigation and Clinical Retrospective Evaluation of Qingyi Granules: Pancreas Cleaner About Ameliorating Severe Acute Pancreatitis with Acute Respiratory Distress Syndrome. Drug Design Development and Therapy. Volume 18. 2043–2061. 2 indexed citations
7.
Miyazaki, Katsuki, Yuji Morine, Caiming Xu, et al.. (2023). Curcumin-Mediated Resistance to Lenvatinib via EGFR Signaling Pathway in Hepatocellular Carcinoma. Cells. 12(4). 612–612. 27 indexed citations
8.
Ge, Peng, Yalan Luo, Guixin Zhang, et al.. (2023). Ferroptosis in Rat Lung Tissue during Severe Acute Pancreatitis-Associated Acute Lung Injury: Protection of Qingyi Decoction. Oxidative Medicine and Cellular Longevity. 2023. 1–22. 10 indexed citations
10.
Xu, Caiming, et al.. (2023). Abstract 1713: TRMT6-mediated N1-methyladenosine methylation promotes tumorigenesis in colorectal cancer. Cancer Research. 83(7_Supplement). 1713–1713.
11.
Xu, Caiming, Yalan Luo, Michael Ntim, et al.. (2021). Effect of emodin on long non‐coding RNA‐mRNA networks in rats with severe acute pancreatitis‐induced acute lung injury. Journal of Cellular and Molecular Medicine. 25(4). 1851–1866. 25 indexed citations
12.
Ge, Peng, Yalan Luo, Haiyang Chen, et al.. (2021). Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Frontiers in Oncology. 11. 667427–667427. 5 indexed citations
13.
Shi, Xiaofeng, Wei Ma, Yongqi Li, et al.. (2020). CircPRKCI relieves lipopolysaccharide‐induced HK2 cell injury by upregulating the expression of miR‐545 target gene ZEB2. BioFactors. 46(3). 475–486. 27 indexed citations
14.
Ge, Peng, Yalan Luo, Haiyang Chen, et al.. (2020). Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis. Biomedicine & Pharmacotherapy. 132. 110770–110770. 139 indexed citations
15.
Shi, Xiaofeng, Wei Ma, Yongquan Pan, et al.. (2020). MiR-126-5p promotes contractile switching of aortic smooth muscle cells by targeting VEPH1 and alleviates Ang II-induced abdominal aortic aneurysm in mice. Laboratory Investigation. 100(12). 1564–1574. 16 indexed citations
16.
Xu, Caiming, Silei Sui, Yuru Shang, et al.. (2020). The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma. Journal of Advanced Research. 24. 139–148. 54 indexed citations
17.
Liu, Jiayue, Jialin Qu, Haiyang Chen, et al.. (2020). The pathogenesis of renal injury in obstructive jaundice: A review of underlying mechanisms, inducible agents and therapeutic strategies. Pharmacological Research. 163. 105311–105311. 19 indexed citations
18.
Shi, Xiaofeng, Wei Ma, Yongqi Li, et al.. (2020). MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: Suppression of TLR2 and OLR1. Journal of Molecular and Cellular Cardiology. 143. 1–14. 30 indexed citations
19.
Xu, Caiming, Yalan Luo, Shuai Li, et al.. (2019). Multifunctional neuron-specific enolase: its role in lung diseases. Bioscience Reports. 39(11). 74 indexed citations
20.
Han, Xiao, Yuxi Wang, Hailong Chen, et al.. (2016). Enhancement of ICAM-1 via the JAK2/STAT3 signaling pathway in a rat model of severe acute pancreatitis-associated lung injury. Experimental and Therapeutic Medicine. 11(3). 788–796. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026